78
Views
2
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive EGFR Mutations: A Single-Center, Open-Label, Single-Arm, Phase II Clinical Trial

, ORCID Icon, , & ORCID Icon
Pages 2557-2567 | Published online: 16 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)